MedPath

comparison of Efficacy of pain relief of Tapentadol nasal spray vs injection diclofenac following laparoscopic surgery.

Phase 3
Conditions
Health Condition 1: K35-K38- Diseases of appendixHealth Condition 2: K80-K87- Disorders of gallbladder, biliary tract and pancreasHealth Condition 3: K40-K46- HerniaHealth Condition 4: O- Medical and SurgicalHealth Condition 5: I861- Scrotal varices
Registration Number
CTRI/2023/10/058950
Lead Sponsor
Sanjay Marwah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

patients undergoing elective laparoscopic surgeries like laparoscopic appendicectomy, laparoscopic cholecystectomy and laparoscopic hernias and varicocele under General anasthesia

american society of anaesthesiologists grade I and II patients aged >18 years

Exclusion Criteria

Patients undergoing emergency surgeries.

conversion to open surgery.

multiple surgeries in same admission.

known allergy to study drug.

refusal to participate in study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the pain scores and rescue analgesia requirement in patients receiving Tapentadol nasal spray and intramuscular Diclofenac sodium injection following laparoscopic procedures.Timepoint: Twenty four hours
Secondary Outcome Measures
NameTimeMethod
side effects of drug, time of mobilization and start of oral feeds, compare of satisfaction score of surgeon in post operative pain controlTimepoint: twenty four hours
© Copyright 2025. All Rights Reserved by MedPath